REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer

BACKGROUND: The regenerating gene Iα (REG Iα) is involved in gastric carcinogenesis as an antiapoptotic factor. Therefore, we investigated whether REG Iα confers resistance to chemotherapeutic drugs in gastric cancer (GC) cells and whether REG Iα expression is useful for predicting the response to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekikawa, A, Fukui, H, Zhang, X, Maruo, T, Tsumura, T, Okabe, Y, Wakasa, T, Osaki, Y, Chiba, T, Tomita, T, Oshima, T, Watari, J, Miwa, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566803/
https://www.ncbi.nlm.nih.gov/pubmed/23322208
http://dx.doi.org/10.1038/bjc.2012.572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566803/
https://www.ncbi.nlm.nih.gov/pubmed/23322208
http://dx.doi.org/10.1038/bjc.2012.572

Ejemplares similares